HomeTagsSecondary Endpoints

Secondary Endpoints

Verona Pharma Announces Ensifentrine Meets Primary and Key Secondary Endpoints

Verona Pharma plc, announces positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics